Sartorius Aktiengesellschaft (VIE:SRT3)

Austria flag Austria · Delayed Price · Currency is EUR
259.00
+10.80 (4.35%)
At close: Dec 3, 2025
20.19%
Market Cap 15.60B
Revenue (ttm) 3.52B
Net Income (ttm) 133.60M
Shares Out n/a
EPS (ttm) n/a
PE Ratio 116.76
Forward PE 40.31
Dividend 0.74 (0.29%)
Ex-Dividend Date Mar 28, 2025
Volume n/a
Average Volume 6
Open 252.80
Previous Close 248.20
Day's Range 252.80 - 259.00
52-Week Range 172.45 - 285.20
Beta n/a
RSI 65.50
Earnings Date Jan 25, 2026

About VIE:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy... [Read more]

Industry Laboratory Analytical Instruments
Founded 1870
Employees 13,528
Stock Exchange Vienna Stock Exchange
Ticker Symbol SRT3
Full Company Profile

Financial Performance

In 2024, VIE:SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.

Financial Statements

News

There is no news available yet.